-
AETHLON MED INC NasdaqCM:AEMD Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device for cancer and life-threatening viral infections and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.
Location: 11555 Sorrento Valley Road, San Diego, CA, 92121, United States | Website: https://www.aethlonmedical.com | Industry: Medical Devices | Sector: Healthcare
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
1.306M
Cash
4.825M
Avg Qtr Burn
-2.135M
Short % of Float
0.69%
Insider Ownership
4.51%
Institutional Own.
21.03%
Qtr Updated
12/31/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|